News/ UK & Europe/ US Novartis less exposed to US pricing pressure, says Jimenez Andrew McConaghie cancer, generics, Novartis, patent, patent expiry, pricing, Trump 0 Comment Europe and Asia account for a large share of company’s income. Share X Novartis less exposed to US pricing pressure, says Jimenez https://pharmaphorum.com/news/novartis-less-exposed-us-pricing-pressure-says-jimenez/